DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ. et al.
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma (mRCC): updated efficacy and safety results and further analysis of prognostic factors.
New Engl J Med 2007;
356: 115-124
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.